ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH

• Status: Completed
• Trial end date: 2004-10-01
• Target enrollment: 0
• Participant gender: Male

Summary

To assess the efficacy of alfuzosin 10mg OD in the management of acute urinary retention associated with BPH.

To assess the safety of alfuzosin in this population and health care consumption.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sanofi
• Treatments: Alfuzosin

Criteria

Inclusion Criteria:

• Male aged over 50 years

• Having given his written consent

• Presenting with a first episode of painful acute urinary retention related to BPH

• With a catheterized urine volume between mL and mL at the time of retention

Exclusion Criteria:

• Associated urological diseases / troubles (e.g. infection or surgery of prostate, urinary retention f neurogenic origin

• Iatrogenic causes of urinary retention